Back
Entero Therapeutics Stock Price Chart
Elon's New AI Device is About to Shock the World
Click here to see the details because a lot of people could get rich from this new invention.
Sell
4
ENTO
Entero Therapeutics
Last Price:
1.76
Seasonality Move:
-38.08%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Nvidia?
Go here now for this breaking story.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENTO is experiencing slight selling pressure.
Entero Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.97 | Sell |
| 20-day SMA: | 2.29 | Sell |
| 50-day SMA: | 2.62 | Sell |
| 200-day SMA: | 4.79 | Sell |
| 8-day EMA: | 1.96 | Sell |
| 20-day EMA: | 2.22 | Sell |
| 50-day EMA: | 2.77 | Sell |
| 200-day EMA: | 69.67 | Sell |
Entero Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 29.4 | Sell |
| Chaikin Money Flow: | -10465 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.03 - 2.75) | Sell |
| Bollinger Bands (100): | (2.31 - 5.59) | Sell |
Entero Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Entero Therapeutics Stock
Is Entero Therapeutics Stock a Buy?
- Entero Therapeutics share price is 1.80 while ENTO 8-day simple moving average is 1.97, which is a Sell signal.
- The stock price of ENTO is 1.80 while Entero Therapeutics 20-day SMA is 2.29, which makes it a Sell.
- Entero Therapeutics 50-day simple moving average is 2.62 while ENTO share price is 1.80, making it a Sell technically.
- ENTO stock price is 1.80 and Entero Therapeutics 200-day simple moving average is 4.79, creating a Sell signal.
ENTO Technical Analysis vs Fundamental Analysis
Sell
4
Entero Therapeutics (ENTO)
is a Sell
Is Entero Therapeutics a Buy or a Sell?
-
Entero Therapeutics stock is rated a Sell
The current Entero Therapeutics [ENTO] share price is $1.80. The Score for ENTO is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
Entero Therapeutics Stock Info
Market Cap:
5.11M
Price in USD:
1.80
Share Volume:
47.09K
Entero Therapeutics 52-Week Range
52-Week High:
33.80
52-Week Low:
1.70
Sell
4
Entero Therapeutics (ENTO)
is a Sell
Entero Therapeutics Share Price Forecast
-
What is the Entero Therapeutics stock price today?
The Entero Therapeutics stock price is 1.80 USD today. -
Will ENTO stock go up or go down?
Entero Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Entero Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entero Therapeutics is overvalued.
Is Entero Therapeutics Stock a Buy?
- Entero Therapeutics share price is 1.80 while ENTO 8-day exponential moving average is 1.96, which is a Sell signal.
- The stock price of ENTO is 1.80 while Entero Therapeutics 20-day EMA is 2.22, which makes it a Sell.
- Entero Therapeutics 50-day exponential moving average is 2.77 while ENTO share price is 1.80, making it a Sell technically.
- ENTO stock price is 1.80 and Entero Therapeutics 200-day simple moving average is 69.67, creating a Sell signal.
Fundamental Analysis of Entero Therapeutics
Is Entero Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $13.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $40.33 per share, and a decrease next year of $0.39 per share.
Technical Analysis of Entero Therapeutics
Should I short Entero Therapeutics stock?
- ENTO Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting Entero Therapeutics is a Sell
- Entero Therapeutics Relative Strength Index (RSI) is 29.4, which suggest Entero Therapeutics is oversold
- The Bollinger Bands (25) for Entero Therapeutics is (2.03 - 2.75), which suggest Entero Therapeutics is a Sell
- The Bollinger Bands (100) for Entero Therapeutics is (2.31 - 5.59), which suggest Entero Therapeutics is a Sell
* Entero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.